touchCARDIO were delighted to talk to Dr Christian-Hendrik Heeger (University Heart Center, Lübeck, Germany) to discuss the ANTARCTICA study, investigating the efficacy and safety of POLARx cryoballoon for pulmonary vein isolation.
The abstract ‘Novel cryoballoon system for pulmonary vein isolation: multicenter assessment of efficacy and safety – The ANTARCTICA study‘ was presented at EHRA 2022, 03-05 April, 2022.
Questions
- Could you give us a brief overview of the POLARx cryoballoon and its potential advantages over other cryoballoon systems? (00:56)
- Could you tell us a little about the ANTARCTICA study and its findings? (02:17)
- What questions remain unanswered and what will be the next steps in the clinical development of the POLARx cryoballoon? (04:31)
Disclosures: Consultant and advisory board for Boston scientific; scientific honoraria/honorarium from Boston scientific; and speaker’s bureau participant with Boston Scientific.
Support:Â Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the annual EHRA Conference 2022.
